Robert L. Hardesty

Overview

Best Publications

• Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

  T.E Starzl;T.E Starzl;K.A Porter;K.A Porter;S Iwatsuki;S Iwatsuki;J.T Rosenthal;J.T Rosenthal

  1720
  Citations

• Venous bypass in clinical liver transplantation.

  Byers W. Shaw;Douglas J. Martin;Jose M. Marquez;Y. G. Kang

  689
  Citations

• Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.

  B F Uretsky;S Murali;P S Reddy;B Rabin

  682
  Citations

• Epstein-Barr Virus Infections and DNA Hybridization Studies in Posttransplantation Lymphoma and Lymphoproliferative Lesions: The Role of Primary Infection

  Monto Ho;George Miller;R. Wayne Atchison;Mary K. Breinig

  649
  Citations

• Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management

  Ko Bando;Irvin L. Paradis;Shari Similo;Hiroaki Konishi

  593
  Citations

• HEART-LIVER TRANSPLANTATION IN A PATIENT WITH FAMILIAL HYPERCHOLESTEROLAEMIA

  T.E. Starzl;T.E. Starzl;H.T. Bahnson;H.T. Bahnson;R.L. Hardesty;R.L. Hardesty;S. Iwatsuki;S. Iwatsuki

  472
  Citations

• Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery.

  Warren M. Breisblatt;Keith L. Stein;Cynthia J. Wolfe;William P. Follansbee

  435
  Citations

• Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.

  Armitage Jm;Kormos Rl;Stuart Rs;Fricker Fj

  426
  Citations

• A Flexible Procedure for Multiple Cadaveric Organ Procurement

  T.E. Starzl;T.R. Hakala;B.W. Shaw;R.L. Hardesty

  412
  Citations

• Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: The Pittsburgh experience

  Srinivas Murali;Robert L Kormos;Barry F Uretsky;David Schechter

  290
  Citations

• Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation.

  Keenan Rj;Lega Me;Dummer Js;Paradis Il

  284
  Citations

• Clinical trial of tacrolimus versus cyclosporine in lung transplantation.

  Robert J. Keenan;Heroaki Konishi;Akihiko Kawai;Irvin L. Paradis

  269
  Citations

• Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine.

  J. Stephen Dummer;Linda T. White;Monto Ho;Bartley P. Griffith

  268
  Citations

• Heart-Lung Transplantation: Lessons Learned and Future Hopes

  Bartley P. Griffith;Robert L. Hardesty;Alfredo Trento;Irvin L. Paradis

  249
  Citations

• Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation.

  Ko Bando;Irvin L. Paradis;Kanshi Komatsu;Hiroaki Konishi

  241
  Citations

• Infections in heart-lung transplant recipients.

  Dummer Js;Montero Cg;Griffith Bp;Hardesty Rl

  230
  Citations

• Cardiac rhythm disturbances early after orthotopic heart transplantation prevalence and clinical importance of the observed abnormalities

  Luc Jacquet;Galal Ziady;Keith Stein;Bartley Griffith

  199
  Citations

• Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension.

  Ko Bando;John M. Armitage;Irvin L. Paradis;Robert J. Keenan

  194
  Citations

• Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation.

  Lavee J;Kormos Rl;Duquesnoy Rj;Zerbe Tr

  190
  Citations

• Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up.

  Arthur Greenberg;Mark E. Thompson;Bartley J. Griffith;Robert L. Hardesty

  189
  Citations